EUVIMEDEUVIMED entdecken
Crossref

Pyridine‐2,6‐Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm

Kajal Chaudhary, Bhumika Agrahari, Bhumika Biswas, Niranjan Chatterjee, Ayushi Chaudhary, Ashwini Kumar, Himanshu Sonker, Sayari Dewan, Deepanshi Saxena, Abdul Akhir, Nidhi Malhotra, Sidharth Chopra und 3 weitere

Advanced Healthcare Materials · 2024-08 · 13 (20)

DOI: 10.1002/adhm.202400378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.04.2024. Verfasst von Kajal Chaudhary und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, IIT, Kanpur, 208016, India. Hauptthemen laut MEDLINE: Biofilms, Staphylococcus aureus, Anti-Bacterial Agents, Zinc. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: DST SERB, INSPIRE Faculty Research Grant, Prime Minister Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pursuit to combat stubborn bacterial infections, particularly those stemming from gram‐positive bacteria, this study is an attempt to craft a precision‐driven platform characterized by unparalleled selectivity, specificity, and synergistic antimicrobial mechanisms. Leveraging remarkable potential of metalloantibiotics in antimicrobial applications, herein, this work rationally designs, synthesizes, and characterizes a new library of Pyridine‐2,6‐dicarboxamide ligands and their corresponding transition metal Cu(II)/Zn(II) complexes. The lead compound L 11 demonstrates robust antibacterial properties against Staphylococcus aureus (Minimum Inhibitory Concentration (MIC) = 2–16 µg mL −1 ), methicillin and vancomycin‐resistant S. aureus (MIC = 2–4 µg mL −1 ) and exhibit superior antibacterial activity when compared to FDA‐approved vancomycin, the drug of last resort. Additionally, the compound exhibits notable antimicrobial efficacy against resistant enterococcus strains (MIC = 2–8 µg mL −1 ). To unravel mechanistic profile, advanced imaging techniques including SEM and AFM are harnessed, collectively suggesting a mechanistic pathway involving cell wall disruption. Live/dead fluorescence studies further confirm efficacy of L 11 and its complexes against S. aureus membranes. This translational exploration extends to a rat model, indicating promising in vivo therapeutic potential. Thus, this comprehensive research initiative has capabilities to transcends the confines of this laboratory, heralding a pivotal step toward combatting antibiotic‐resistant pathogens and advancing the frontiers of metalloantibiotics‐based therapy with a profound clinical implication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsStaphylococcus aureusAnti-Bacterial AgentsZincCopperMicrobial Sensitivity TestsPyridinesAnimalsRatsCoordination ComplexesStaphylococcal InfectionsLigandsRats, Sprague-Dawley

Stichwörter der Autor:innen

MRSA/VRSAS. aureusmetalloantibioticsresistant

Substanzen

Anti-Bacterial AgentsZincCopperPyridinesCoordination ComplexesLigands

Autor:innen und Institutionen

  • Department of Chemistry, IIT, Kanpur, 208016, India.
  • Department of Biological Sciences and Bioengineering, IIT, Kanpur, 208016, India.
  • Division of Microbiology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
  • Department of Chemistry, School of Natural Sciences, Shiv Nadar Institution of Eminence, Gautam Budh Nagar, 201314, India.

ORCID-Profile: Ritika Gautam Singh

Förderung

  • DST SERB
  • INSPIRE Faculty Research Grant
  • Prime Minister Research Grant
  • TTI Division of DST

Zitieren

APA

Chaudhary, K., Agrahari, B., Biswas, B., Chatterjee, N., Chaudhary, A., Kumar, A., Sonker, H., Dewan, S., Saxena, D., Akhir, A., Malhotra, N., Chopra, S., Misra, S., Matheswaran, S., & Singh, R. G. (2024). Pyridine‐2,6‐Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202400378

Vancouver

Chaudhary K, Agrahari B, Biswas B, Chatterjee N, Chaudhary A, Kumar A, et al. Pyridine‐2,6‐Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202400378

BibTeX
@article{Chaudhary2024,
  author = {Chaudhary, Kajal and Agrahari, Bhumika and Biswas, Bhumika and Chatterjee, Niranjan and Chaudhary, Ayushi and Kumar, Ashwini and Sonker, Himanshu and Dewan, Sayari and Saxena, Deepanshi and Akhir, Abdul and Malhotra, Nidhi and Chopra, Sidharth and Misra, Santosh and Matheswaran, Saravanan and Singh, Ritika Gautam},
  title = {Pyridine‐2,6‐Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1002/adhm.202400378}
}
Kostenlos starten →